Raziya Bobat
Raziya Bobat has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
A Coutsoudis
2 shared publicationsD Moodley
2 shared publicationsD. Moodley
2 shared publicationsA. Violari
1 shared publicationA.J. Loftis
1 shared publicationA.S. Coletti
1 shared publication
Latest Publications
- 1 September 2017
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 37 (3) , 154-155
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
(N Engl J Med. 2016;375(18):1726–1737) Although triple-drug antiretroviral therapy (ART) has clear benefits for mothers and infants, studies have shown higher rates of adverse pregnancy outcomes with maternal ART than with regimens containing fewer antiretroviral agents. The Promoting Maternal and Infant Survival Everywhere (PROMISE) trial thus compared the relative efficacy and safety of various open-label antiretroviral strategies and their effect on preventing mother-to-child transmission among asymptomatic HIV-infected pregnant women with high CD4 counts (at least 350 cells/mm3).
- 1 September 2017
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 37 (3) , 154-155
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
(N Engl J Med. 2016;375(18):1726–1737) Although triple-drug antiretroviral therapy (ART) has clear benefits for mothers and infants, studies have shown higher rates of adverse pregnancy outcomes with maternal ART than with regimens containing fewer antiretroviral agents. The Promoting Maternal and Infant Survival Everywhere (PROMISE) trial thus compared the relative efficacy and safety of various open-label antiretroviral strategies and their effect on preventing mother-to-child transmission among asymptomatic HIV-infected pregnant women with high CD4 counts (at least 350 cells/mm3).
- 1 March 2006
- Published by Elsevier in Revue Française des Laboratoires
- Vol. 2006 (380) , 14
VIH et supplémentation en zinc
- 1 March 2006
- Published by Elsevier in Revue Française des Laboratoires
- Vol. 2006 (380) , 14
VIH et supplémentation en zinc
- 1 September 2001
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 21 (3) , 203-210
Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa
This study describes growth in a cohort of black South African children born to HIV-1-infected women in Durban. Children born to HIV-1-seropositive women were followed up from birth to early childhood. At birth and at each visit, growth parameters were measured. Mean Z-scores were calculated for weight-for-length, weight-for-age and length-for-age and, if they were low, the children were regarded as wasted, malnourished or stunted, respectively. At the end of the study, there were 48 infected and 93 uninfected children. There were no significant differences between the two groups at birth. Thereafter, the infected group was found to have early and sustained low mean Z-scores for length-for-age and weight-forage but not for weight-for-length. The means reached significance at ages 3, 6 and 12 months for length and at 3, 6 and 9 months for weight. Infected children who died early had more severe stunting, wasting and malnutrition than infected children who survived. Infected children born to HIV-positive women have early and sustained stunting and are malnourished but not wasted. Children with rapidly progressive disease have both stunting and wasting and are more severely affected. Early nutritional intervention might help prevent early progression or death in HIV-infected children, particularly in developing countries without access to anti-retroviral therapy in state hospitals.
- 1 September 2001
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 21 (3) , 203-210
Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa
This study describes growth in a cohort of black South African children born to HIV-1-infected women in Durban. Children born to HIV-1-seropositive women were followed up from birth to early childhood. At birth and at each visit, growth parameters were measured. Mean Z-scores were calculated for weight-for-length, weight-for-age and length-for-age and, if they were low, the children were regarded as wasted, malnourished or stunted, respectively. At the end of the study, there were 48 infected and 93 uninfected children. There were no significant differences between the two groups at birth. Thereafter, the infected group was found to have early and sustained low mean Z-scores for length-for-age and weight-forage but not for weight-for-length. The means reached significance at ages 3, 6 and 12 months for length and at 3, 6 and 9 months for weight. Infected children who died early had more severe stunting, wasting and malnutrition than infected children who survived. Infected children born to HIV-positive women have early and sustained stunting and are malnourished but not wasted. Children with rapidly progressive disease have both stunting and wasting and are more severely affected. Early nutritional intervention might help prevent early progression or death in HIV-infected children, particularly in developing countries without access to anti-retroviral therapy in state hospitals.
- 1 June 1999
- Vol. 89 (6) , 646-8
Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa.
To describe mortality in a cohort of infants with vertically transmitted HIV-1 infection. Children of HIV-1 infected women were followed up from birth and a record was made at each visit of growth, development and all illnesses. Details surrounding death were obtained from hospital records. The final cohort comprised 48 infected and 93 uninfected children; there were 25 deaths, 17 of which (35%) were regarded as being HIV-related. The mean age at death of HIV-related cases was 10.1 months (range 1-48 months), with 83% of HIV-related deaths occurring before the age of 10 months. The commonest diagnoses at the time of death were diarrhoea, pneumonia, failure to thrive and severe thrush. These findings, together with neurological abnormalities, often presaged rapid deterioration and death. Mortality among children with vertically acquired HIV infection is high in the first year of life. Death in these subjects was due to the common causes of morbidity and mortality among all children in developing countries. A combination of diarrhoea, pneumonia, failure to thrive, and neurological abnormalities should alert one to the possibility of rapidly progressive disease and death.
- 1 June 1999
- Vol. 89 (6) , 646-8
Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa.
To describe mortality in a cohort of infants with vertically transmitted HIV-1 infection. Children of HIV-1 infected women were followed up from birth and a record was made at each visit of growth, development and all illnesses. Details surrounding death were obtained from hospital records. The final cohort comprised 48 infected and 93 uninfected children; there were 25 deaths, 17 of which (35%) were regarded as being HIV-related. The mean age at death of HIV-related cases was 10.1 months (range 1-48 months), with 83% of HIV-related deaths occurring before the age of 10 months. The commonest diagnoses at the time of death were diarrhoea, pneumonia, failure to thrive and severe thrush. These findings, together with neurological abnormalities, often presaged rapid deterioration and death. Mortality among children with vertically acquired HIV infection is high in the first year of life. Death in these subjects was due to the common causes of morbidity and mortality among all children in developing countries. A combination of diarrhoea, pneumonia, failure to thrive, and neurological abnormalities should alert one to the possibility of rapidly progressive disease and death.
- 1 May 1997
- Published by Wiley in Tropical Medicine & International Health
- Vol. 2 (5) , 415-421
Lymphocyte subset changes between 3 and 15 months of age in infants born to HIV-seropositive women in South Africa
- 1 May 1997
- Published by Wiley in Tropical Medicine & International Health
- Vol. 2 (5) , 415-421
Lymphocyte subset changes between 3 and 15 months of age in infants born to HIV-seropositive women in South Africa
- 1 June 1995
- Vol. 85 (6) , 495
Moving from AIDS to symptomatic HIV infection.